Ureter Cancer Clinical Trials in New York

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Afatinib in Advanced Refractory Urothelial Cancer
Recruiting
  • Distal Urethral Cancer
  • +8 more
  • afatinib dimaleate
  • laboratory biomarker analysis
  • Atlanta, Georgia
  • +5 more
2021-09-24
Sep 24, 2021
M
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
  • Urothelial Cancer
  • +3 more
  • saliva sample and questionaire
  • saliva sample, questionaire
  • Basking Ridge, New Jersey
  • +3 more
2021-06-02
Jun 2, 2021
M
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies - 2016
Completed
  • Bladder Cancer
  • +2 more
  • gemcitabine and split-dose cisplatin plus escalating doses of continuous Everolimus (RAD001)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2016-03-29
Mar 29, 2016
A
A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer - 2009
Completed
Has Results
  • Bladder Cancer
  • +4 more
  • Palo Alto, California
  • +35 more
2010-12-13
Dec 13, 2010